NFKB1 and Timothy syndrome: The miR-429 targeted IKKβ binding to regulate the NF-κB pathway and inhibit the release of pro-inflammatory factors, thus, controlling neuroinflammation in microglia, which may be the mechanism of action of miR-429 in TS.